The Journal of Steroid Biochemistry and Molecular Biology 2014-07-01

The “newer” progestogens and postmenopausal hormone therapy (HRT)

Adolf E. Schindler

Index: J. Steroid Biochem. Mol. Biol. 142 , 48-51, (2014)

Full Text: HTML

Abstract

• The “newer” progestogens have a high bioavailability. • The “newer” progestogens have a sufficient progestogenic effect. • The “newer” progestogens do not cause undue side effects. • The “newer” progestogens do not jeopardize lipid- and carbohydrate metabolism.

Related Compounds

Related Articles:

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.

2008-04-10

[J. Med. Chem. 51 , 2047-56, (2008)]

The Development and Single-Laboratory Validation of a Method for the Determination of Steroid Residues in Fish and Fish Products.

2015-01-01

[J. AOAC Int. 98 , 580-7, (2015)]

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

2008-10-09

[J. Med. Chem. 51 , 5932-42, (2008)]

Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

2008-06-12

[J. Med. Chem. 51 , 3275-87, (2008)]

More Articles...